Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sisi Fu
Institutions:
Hangzhou Normal University,
Affiliated Hospital of Hangzhou Normal University
Observed institutions:
Hangzhou Normal University,
Affiliated Hospital of Hangzhou Normal University,
HUTCHMED (China) Limited (China),
Chongqing Medical University
ORCID:
0009-0008-0143-0447
Observed ORCIDs:
0009-0008-0143-0447,
0009-0005-2315-1711
OpenAlex ID:
A5044405278
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study
2024
·
Yu Hu
, Xiaofan Liu
, et al.
·
The Lancet Haematology
·
37
Cryptotanshinone promotes brown fat activity by AMPK activation to inhibit obesity
2024
·
Jie Ni
, Aili Ye
, et al.
·
Nutrition Research and Practice
·
9
PDF
Phase I study of the Syk inhibitor sovleplenib in relapsed or refractory mature B-cell tumors
2024
·
Yuqin Song
, Junning Cao
, et al.
·
Haematologica
·
5
PDF
Comparison of neuropathy symptom score/neuropathy disability score and nerve conduction velocities in the diagnosis of diabetic peripheral neuropathy
2014
·
Wenqu Liu
, Zhihong Wang
, et al.
·
Chin J Diabetes Mellitus
·
1
Amelioration of chronic inflammation, insulin resistance, and gut microbiota homeostasis by a combination of Bifidobacterium , Lactobacillus , Enterococcus , and Bacillus in obese type 2 diabetic mice
2026
·
Sisi Fu
, Fei Zhou
, et al.
·
Nutrition Research and Practice
Impact of family history of type 2 diabetes mellitus on pancreatic β-cell function and insulin sensitivity in metabolically healthy overweight/obese individuals
2015
·
Sisi Fu
, Zhihong Wang
, et al.
·
Chin J Diabetes Mellitus
Show more works
View as search
Works count:
6
Citation count:
52
H-index:
3
I10-index:
1
Year
Topic
Type